Literature DB >> 6282509

The effects of T-cell growth factor and virus purification on virus-mediated inhibition of lymphocyte mitogenesis.

M A Wainberg, R G Margolese.   

Abstract

Many different types of virus particles are able to non-specifically impede the ability of human peripheral blood lymphocytes to respond to mitogenic ro alloantigenic stimuli. This result is not obtained if ultra-purified virus is employed, although virus which has been banded only once through sucrose generally retains inhibitory potential. Ultra-pure virus is relatively unable to bind to cell surfaces, suggesting the importance of physical contact between viruses and cells in order for the observed inhibition to occur. Addition of exogenous T-cell growth factor (TCGF) to cultures containing virus, cells and stimulus causes a dose-dependent reversal of the usual inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282509      PMCID: PMC1536554     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

Authors:  P D Walzer; D P Perl; D J Krogstad; P G Rawson; M G Schultz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

2.  Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

3.  Evidence for a macrophage-mediated effect of poliovirus on the lymphocyte response to phytohemagglutinin.

Authors:  F J Soontiëns; J van der Veen
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

4.  Infection-mediated resistance to cell fusion by inactive Sendai virus.

Authors:  M A Wainberg; C Howe
Journal:  Proc Soc Exp Biol Med       Date:  1973-03

5.  Affinity chromatography of avian type C viral reverse transcriptase: studies with Rous sarcoma virus transformed rat cells.

Authors:  D M Livingston; W P Parks; E M Scolnick; J Ross
Journal:  Virology       Date:  1972-11       Impact factor: 3.616

6.  Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis.

Authors:  F T Willems; J L Melnick; W E Rawls
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

7.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus.

Authors:  T A Kupers; J M Petrich; A W Holloway; J W St Geme
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

9.  Iron-binding catechols and virulence in Escherichia coli.

Authors:  H J Rogers
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Abnormalities of in vitro lymphocyte responses during rubella virus infections.

Authors:  G B Olson; P B Dent; W E Rawls; M A South; J R Montgomery; J L Melnick; R A Good
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  4 in total

1.  Reversible interference with TCGF activity by virus particles.

Authors:  M A Wainberg; S Vydelingum; M Boushira; J Legacé-Simard; R G Margolese; B Spira; J Mendelson
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

2.  Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system.

Authors:  G Colonna Romano; F Dieli; S Abrignani; A Salerno; V Colizzi
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  The role of virus dose in experimental bovine leukemia virus infection in sheep.

Authors:  T Stirtzinger; V E Valli; J M Miller
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

4.  Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancer.

Authors:  R G Margolese; M A Wainberg
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.